◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

辰欣药业

辰欣药业
Loading...
Price History
Market Data
Market Cap7.3B
P/E Ratio-
P/B Ratio-
EPS1.12
Dividend Yield-
D/E Ratio0.26
Current Ratio3.33
Market SegmentMain Board
CurrencyCNY
Business Overview

Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, research, develops, produces, and sells drug products in China and internationally. The company's chemical preparations include basic infusion, therapeutic infusion, liver disease medication, nervous system drugs, anti-tumor and adjuvant drugs, nutritional infusion, contrast agents, cardiovascular and cerebrovascular drugs, anti-infective drugs, narcotic analgesics, obstetrics and gynecology medication, digestive system medication, respiratory system medication, immune system drugs, and hormonal drugs. It also offers Chinese medicine preparations; complete and incomplete nutritional formula food; specific nutritionally complete formula foods; nutritious food; health food; API; and packaging products. The company was formerly known as Shandong Lukang Cisen Pharmaceutical Co., Ltd. and changed its name to Cisen Pharmaceutical Co., Ltd. in 2011. Cisen Pharmaceutical Co., Ltd. was founded in 1970 and is headquartered in Jining, the People's Republic of China.

CSRC Classification Pharmaceutical Manufacturing SSE
Key Financial Metrics
4.0B
Revenue
515.0M
Net Income
1.12
EPS (Diluted)
469.0M
Free Cash Flow
Profitability
Gross Margin -
Operating Margin 14.4%
Net Profit Margin 12.9%
EBITDA 572.0M
Returns & Efficiency
Return on Assets (ROA) 6.8%
Return on Equity (ROE) 8.6%
Dividend Yield -
EPS 1.12
Financial Health
Total Assets 7.6B
Total Debt 1.6B
Debt to Equity 0.26x
Current Ratio 3.33
Company Info
IndustryPharmaceutical Manufacturing
Market SegmentMain Board
CurrencyCNY
Fiscal Year2024
Peers
2.7T
P/E: 7.6
2.5T
P/E: 7.2
2.4T
P/E: 8.7
CNOOC LIMITED
600938
2.0T
P/E: 16.2
1.9T
P/E: 25.6
1.8T
P/E: 20.1
1.8T
P/E: 7.3
1.2T
P/E: 6.9
Stock Chart
Open Full Chart View

Full charting with technical indicators, candlestick, line charts, and more.

Company Profile
General Information
Company Name辰欣药业
Ticker603367
ExchangeSSE
SectorCSRC Classification
IndustryPharmaceutical Manufacturing
Market SegmentMain Board
Fiscal Year2024
CurrencyCNY
Financial Summary
Market Cap7.3B
Revenue4.0B
Net Income515.0M
P/E Ratio-
EPS1.12
Net Margin12.9%
ROE8.6%
Dividend Yield-
Description

Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, research, develops, produces, and sells drug products in China and internationally. The company's chemical preparations include basic infusion, therapeutic infusion, liver disease medication, nervous system drugs, anti-tumor and adjuvant drugs, nutritional infusion, contrast agents, cardiovascular and cerebrovascular drugs, anti-infective drugs, narcotic analgesics, obstetrics and gynecology medication, digestive system medication, respiratory system medication, immune system drugs, and hormonal drugs. It also offers Chinese medicine preparations; complete and incomplete nutritional formula food; specific nutritionally complete formula foods; nutritious food; health food; API; and packaging products. The company was formerly known as Shandong Lukang Cisen Pharmaceutical Co., Ltd. and changed its name to Cisen Pharmaceutical Co., Ltd. in 2011. Cisen Pharmaceutical Co., Ltd. was founded in 1970 and is headquartered in Jining, the People's Republic of China.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...